Screener
ResMed RMD EBIT
Discontinued — last reported Q4 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from ResMed’s reported figures.
The source filing: ResMed’s 8-K, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Accession
- 0001193125-26-337962
FAQ
- What is ResMed's EBIT?
- ResMed (RMD) reported EBIT of $448.71M in Q2 2026.
- How has ResMed's EBIT changed year-over-year?
- ResMed's EBIT decreased by 1.3% year-over-year, from $454.54M to $448.71M.
- What is the long-term trend for ResMed's EBIT?
- Over 4 years (2022 to 2026), ResMed's EBIT has grown at a 17.2% compound annual growth rate (CAGR), from $1B to $1.89B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about ResMed's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude